Mike Kratky
Stock Analyst at Leerink Partners
(3.55)
# 909
Out of 4,761 analysts
26
Total ratings
50%
Success rate
41.17%
Average return
Main Sectors:
Stocks Rated by Mike Kratky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TXG 10x Genomics | Downgrades: Market Perform | $25 → $12 | $10.90 | +10.09% | 2 | Feb 13, 2025 | |
| DXCM DexCom | Maintains: Outperform | $90 → $87 | $88.78 | -2.00% | 2 | Oct 25, 2024 | |
| INSP Inspire Medical Systems | Maintains: Market Perform | $167 → $197 | $177.32 | +11.10% | 2 | Sep 10, 2024 | |
| PEN Penumbra | Initiates: Outperform | $263 | $291.68 | -9.83% | 1 | Sep 3, 2024 | |
| TNDM Tandem Diabetes Care | Upgrades: Outperform | $34 → $45 | $31.00 | +45.16% | 2 | Apr 25, 2024 | |
| NPCE NeuroPace | Initiates: Outperform | $22 | $13.77 | +59.77% | 1 | Jan 30, 2024 | |
| PODD Insulet | Initiates: Outperform | $184 | $282.80 | -34.94% | 1 | Oct 16, 2023 | |
| VCEL Vericel | Initiates: Outperform | $42 | $52.00 | -19.23% | 1 | Oct 16, 2023 | |
| ISRG Intuitive Surgical | Initiates: Outperform | $342 | $591.79 | -42.21% | 1 | Oct 16, 2023 | |
| EW Edwards Lifesciences | Initiates: Market Perform | $75 | $73.30 | +2.32% | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $37 | $62.25 | -40.56% | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $9 | $18.00 | -50.00% | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $325 → $50 | $4.51 | +1,008.65% | 2 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $45 | $3.08 | +1,361.04% | 2 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $145 → $315 | $336.23 | -6.31% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $26 → $31 | $36.81 | -15.78% | 2 | Dec 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $14 | $21.27 | -34.18% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $40 | $16.27 | +145.85% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $49 → $48 | $1.25 | +3,740.00% | 1 | Aug 11, 2022 |
10x Genomics
Feb 13, 2025
Downgrades: Market Perform
Price Target: $25 → $12
Current: $10.90
Upside: +10.09%
DexCom
Oct 25, 2024
Maintains: Outperform
Price Target: $90 → $87
Current: $88.78
Upside: -2.00%
Inspire Medical Systems
Sep 10, 2024
Maintains: Market Perform
Price Target: $167 → $197
Current: $177.32
Upside: +11.10%
Penumbra
Sep 3, 2024
Initiates: Outperform
Price Target: $263
Current: $291.68
Upside: -9.83%
Tandem Diabetes Care
Apr 25, 2024
Upgrades: Outperform
Price Target: $34 → $45
Current: $31.00
Upside: +45.16%
NeuroPace
Jan 30, 2024
Initiates: Outperform
Price Target: $22
Current: $13.77
Upside: +59.77%
Insulet
Oct 16, 2023
Initiates: Outperform
Price Target: $184
Current: $282.80
Upside: -34.94%
Vericel
Oct 16, 2023
Initiates: Outperform
Price Target: $42
Current: $52.00
Upside: -19.23%
Intuitive Surgical
Oct 16, 2023
Initiates: Outperform
Price Target: $342
Current: $591.79
Upside: -42.21%
Edwards Lifesciences
Oct 16, 2023
Initiates: Market Perform
Price Target: $75
Current: $73.30
Upside: +2.32%
Oct 16, 2023
Initiates: Outperform
Price Target: $37
Current: $62.25
Upside: -40.56%
Oct 16, 2023
Initiates: Outperform
Price Target: $9
Current: $18.00
Upside: -50.00%
Aug 15, 2023
Downgrades: Market Perform
Price Target: $325 → $50
Current: $4.51
Upside: +1,008.65%
Jan 24, 2023
Maintains: Outperform
Price Target: $33 → $45
Current: $3.08
Upside: +1,361.04%
Dec 20, 2022
Maintains: Outperform
Price Target: $145 → $315
Current: $336.23
Upside: -6.31%
Dec 15, 2022
Maintains: Market Perform
Price Target: $26 → $31
Current: $36.81
Upside: -15.78%
Nov 4, 2022
Maintains: Outperform
Price Target: $12 → $14
Current: $21.27
Upside: -34.18%
Aug 15, 2022
Maintains: Outperform
Price Target: $32 → $40
Current: $16.27
Upside: +145.85%
Aug 11, 2022
Maintains: Outperform
Price Target: $49 → $48
Current: $1.25
Upside: +3,740.00%